key: cord-0696718-jumtg11o authors: Chen, Jingqing; Jin, Yuhang; Yang, Ying; Wu, Zhenlong; Wu, Guoyao title: Epithelial Dysfunction in Lung Diseases: Effects of Amino Acids and Potential Mechanisms date: 2020-08-07 journal: Amino Acids in Nutrition and Health DOI: 10.1007/978-3-030-45328-2_4 sha: bc6e12821a24458cdf83079d81caa66ade60bc87 doc_id: 696718 cord_uid: jumtg11o Lung diseases affect millions of individuals all over the world. Various environmental factors, such as toxins, chemical pollutants, detergents, viruses, bacteria, microbial dysbiosis, and allergens, contribute to the development of respiratory disorders. Exposure to these factors activates stress responses in host cells and disrupt lung homeostasis, therefore leading to dysfunctional epithelial barriers. Despite significant advances in therapeutic treatments for lung diseases in the last two decades, novel interventional targets are imperative, considering the side effects and limited efficacy in patients treated with currently available drugs. Nutrients, such as amino acids (e.g., arginine, glutamine, glycine, proline, taurine, and tryptophan), peptides, and bioactive molecules, have attracted more and more attention due to their abilities to reduce oxidative stress, inhibit apoptosis, and regulate immune responses, thereby improving epithelial barriers. In this review, we summarize recent advances in amino acid metabolism in the lungs, as well as multifaceted functions of amino acids in attenuating inflammatory lung diseases based on data from studies with both human patients and animal models. The underlying mechanisms for the effects of physiological amino acids are likely complex and involve cell signaling, gene expression, and anti-oxidative reactions. The beneficial effects of amino acids are expected to improve the respiratory health and well-being of humans and other animals. Because viruses (e.g., coronavirus) and environmental pollutants (e.g., PM2.5 particles) induce severe damage to the lungs, it is important to determine whether dietary supplementation or intravenous administration of individual functional amino acids (e.g., arginine-HCl, citrulline, N-acetylcysteine, glutamine, glycine, proline and tryptophan) or their combinations to affected subjects may alleviate injury and dysfunction in this vital organ. The lungs are the foundational organs of the respiratory system, whose most important function is to facilitate gas exchange between the environment and the bloodstream . In this process called respiration, oxygen in the ambient air enters the blood, whereas CO 2 (a product of nutrient metabolism) leaves the blood. Structurally, the bronchial monolayer epithelium in the respiratory system is responsible for preserving airway homeostasis in the lungs. Disruption of the barrier integrity by various stimuli, such as toxins, chemical pollutants, detergents, viruses, bacteria, microbial dysbiosis, and allergens, can contribute to the development of lung diseases (Budden et al. 2017; Georas and Rezaee 2014) . Biochemically, these endogenous or exogenous risk factors activate an abnormal inflammatory response in the respiratory system, leading to the accumulation of reactive oxygen species (ROS), the breakdown of the epithelial integrity in the airways and alveoli, and ultimately reduced airflow capacity and lung dysfunction (Agusti and Hogg 2019; Guo and Ward 2007; Lang et al. 2002; Rahman et al. 2005; Zhang et al. 2018) . Despite significant advances in the pathogenesis of lung diseases in the last two decades, currently clinical therapies for lung diseases are largely dependent on the application of bronchodilators or glucocorticoids to improve airflow and ameliorate clinic symptoms in patients (Atto et al. 2019; Boskabadi et al. 2018; Bream-Rouwenhorst et al. 2008; Grainge and Rice 2010) . Growing evidence has shown that the impairment of epithelial barrier in the alveoli is a critical step for the initiation and development of lung diseases (Steelant 2020) . In our recent study, we found that dietary supplementation with L-arginine or glycine reduced immune cell infiltration, decreased mRNA levels for inflammatory cytokines and chemokines, and decreased the apoptosis of alveolar cells in LPS-challenged mice (Ma et al. 2019) . These findings provide a new nutritional strategy to ameliorate lung injury through oral administration of functional amino acids. In this article, we reviewed recent progress in epithelial barrier biology and pathobiology related to lung disease. We also discussed potential mechanisms responsible for the beneficial effects of some amino acids in human patients and animal models. The lung is made up of dozens of cell types and has evolved architecturally into a series of branching airways and alveoli to support an efficient permeable transfer of oxygen and carbon dioxide for the respiratory system and the whole body (Warheit-Niemi et al. 2019 ). An appropriate function of the lung is predominantly dependent on the alveolar epithelial cells, one of the predominant cells in the respiratory tract ( Fig. 4.1) . Under physiological conditions, the intracellular homeostasis and the normal function of the lungs are maintained through nutrient metabolism and its regulation. However, following a severe or prolonged insult or injury to the alveolar epithelial cells, over-activation of immune responses leads to the accumulation of ROS, increased infiltration by immunocytes, and impaired function of the lungs (Kosmider et al. 2011; Steelant 2020) . The neighboring alveolar epithelial cell of the respiratory airway are held together by tight junctions (TJs) and adherens junctions, therefore forming a physical barrier against external particles and a first line of defense of the mucosal immunity (Georas and Rezaee 2014; Lambrecht and Hammad 2014) . Similar to TJ proteins in the gas- Functional amino acids activate Nrf2 survival signaling, while inhibiting NRLP3 inflammasome to alleviate lung injury. Air pollutants, cigarette smoke and bacterial or viral infections cause oxidative stress and inflammation in the lungs. Nrf2 activation induces the expression of cytoprotective genes to counteract the toxic effect of ROS and inhibits the transcription of proinflammatory cytokines, especially in macrophages, to reduce the recruitment of inflammatory cells into the lungs. Increased levels of ROS reduce Nrf2 and activate inflam-masome, leading to the upregulation of IL-1β, IL-6, and TNF-α expression as well as the death of lung epithelial cells and consequently emphysema. Functional amino acids such as Arg, Gln, Gly activate the Nrf2 survival signaling to increase the expression of anti-oxidative genes possibly through modulating the NLRP3 inflammasome to inhibit the pro-inflammatory factors, thus improving the lung epithelial barrier. Arg, L-arginine; Gly, glycine; Gln, L-glutamine; IL, interleukin; ROS, reactive oxygen species; Nrf2, nuclear factor erythroid 2-related factor 2 trointestinal tract, the claudin family proteins, occludin, and scaffolding proteins, such as zonulae occludens (ZO)-1, ZO-2, ZO-3, multi-PDZ domain protein 1, and others, have been identified as main components of the TJ complexes in the lungs (Sugita et al. 2018) . A decrease in the abundance of TJ proteins and an increase in the epithelial permeability have been observed in multiply lung diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic lung inflammation (Georas and Rezaee 2014; Lambrecht and Hammad 2014; Tatsuta et al. 2019) . Disruption of TJs with a leaking epithelium allows a close contact of airway lumen contents (including pathogens, allergens, and toxins) with immune cells, triggering the activation of inflammatory responses (Mattila et al. 2011; Wang et al. 2019; Wieczfinska et al. 2015) . In addition, the respiratory fluid, mucus, surfactant proteins, and the motility of cilia are critical for the mucosal barrier function and the innate immune response by promoting the elimination of luminal contents. If this defense system is impaired or cannot be repaired, epithelial damage and lung dysfunction will occur (Price and Sisson 2019). Consistently, therapeutic molecules with an ability to regulate the abundances of TJ proteins and surfactant proteins, as well as the secretion of the mucins have been reported to improve mucosal barrier integrity and lung function in human patients and animal models (Boskabadi et al. 2018; Kouis et al. 2018; Ma et al. 2019; Marudamuthu et al. 2019 ). Amino acids enter the lungs from the blood circulation via various sodium-dependent and independent transporters (Table 4 .1). There is no de novo synthesis of citrulline, arginine, cysteine, three branched-chain AAs (BCAAs; isoleucine, leucine and valine), methionine, phenylalanine, taurine, threonine, tryptophan, tyrosine, histidine, or lysine in the lungs (Wu 2013) . In addition, the lungs lack: (a) the transsulfuration pathway for converting methionine into cysteine (Berggren et al. 1984 ); (b) phenylalanine hydroxylase for converting phenylalanine into tyrosine (McGee et al. 1972) ; and (c) enzymes for converting taurine, threonine, tryptophan, tyrosine, histidine, or lysine into pyruvate, acetyl-CoA or the intermediates of the Krebs cycle (Wu 2013) . However, the lungs can synthesize: (a) arginine from citrulline via argininosuccinate synthase and lyase (Wu and Morris Jr. 1998 ); (b) ornithine and proline from arginine via arginase-II, ornithine aminotransferase, and pyrroline-5-carboxylate reductase; (c) alanine, glutamate and glutamine from BCAAs plus α-ketoglutarate (α-KG) via BCAA transaminase, glutamate transaminase, and glutamine synthetase (Souba et al. 1990 ); and (d) glutamate and aspartate from glutamine via phosphate-activated glutaminase, glutamate: pyruvate transaminase (alanine transaminase), and glutamate: oxaloacetate transaminase (aspartate transaminase); and (e) ornithine from proline via proline oxidase and ornithine aminotransferase (mitochondrial enzymes; Wu et al. 1997 ). These synthetic reactions also serve as metabolic pathways for the catabolism of arginine, alanine, glutamate, glutamine, aspartate, and proline in the lungs. In addition, serine and glycine are interconvertible in this organ through the action of serine hydroxymethyltransferase (present in both the cytosol and mitochondria), which plays an important role in both pulmonary health and the treatment of lung cancer (Amelio et al. 2014) . Furthermore, in all cell types of the lungs (including macrophages, endothelial cells, epithelial cells, and smooth muscle cells), nitric oxide (NO; a major vasodilator and signaling molecule) and citrulline are generated from arginine by NO synthase (Folkerts et al. 2001) , whereas ornithine decarboxylase decarboxylates ornithine to form putrescine (Hoet and Nemery 2000) . The latter is converted into spermidine and spermine by decarboxylated 5-adenosylmethionine-dpendent spermidine synthase and spermine synthase (cytosolic enzymes), respectively. The polyamines (putrescine, spermidine and spermine) are essential for DNA and protein syntheses and, therefore, play an important role in pulmonary health and diseases (including lung cancer; Agostinelli et al. 2020) . During sepsis or LPS infection, the lungs export an increased amount of glutamine by inducing the expression of glutamine synthetase at the transcriptional level partially mediated by glucocorticoid hormones (Lukaszewicz et al. 1997 ). Besides serving as building blocks for proteins, which are the most fundamental component in tissues, amino acids have enormous physiologi-cal importance, such as the synthesis of low molecular-weight substances (e.g., nitric oxide, polyamines, creatine, carnosine, dopamine, serotonin, and glutathione), regulate metabolism and immune response, and maintain intestinal barrier function (Wu 2013; Wu et al. 2014 ). Based on studies on the fundamental effects of amino acids, as well as their metabolism and biological functions, a new concept of "functional amino acid" has been proposed (Hou and Wu 2017) . In contrast to the traditional classification of nutritionally essential or non-essential amino acids, which were defined based on the criterion of growth or nitrogen balance, the con- Adapted from Kanai and Hediger (1992) , Kandasamy et al. (2018) and Wu (2013) HC-HAAT heavy chain of heteromeric amino acid transporter, HHH hyperornithinemia-hyperammonemia-homocitrullinuria, LCT lysosomal cystine transporter, MGT mitochondrial glycine transporter, it mitochondrial, NKHG non-ketotic hyperglycemia, rBAT related to b o,+ amino acid transporters cept of "functional amino acids" is based on physiological functions of amino acids to improve survival, growth, development, lactation, reproduction, and health of humans and other animals (Wu 2014 ). This view advances our understating of amino acid nutrition and metabolism, as well as dietary requirements for amino acids to maintain various functions of cells and tissues under both physiological and pathological conditions. Accumulating evidence has shown that functional amino acids are critical for the regulation of protein synthesis, gene expression, immune response, intestinal barrier function, and cellular fate decision (Hou et al. 2015; Wu et al. 2014 ). The pulmonary epithelium is the predominant cells that prevent the entry of luminal contents into the blood circulation, while ensuring proper gas exchange. A relationship between low TJ protein abundance and high epithelial permeability has been reported for the gastrointestinal or respiratory epithelium of human patients and animal models (He et al. 2017) . This observation supports a critical role of TJ proteins in epithelial integrity and prompts new search for molecules or compounds to reduce epithelial permeability and improve mucosal barrier function using both in vivo or in vitro models (Atto et al. 2019) . A comparative study has identified differences in the metabolism of amino acids between patients with and without bacterial infection during the early stage of chronic obstructive pulmonary disease (COPD) (32). Specifically, COPD patients affected with bacterial infection had lung dysfunction, which was accompanied by decreased plasma levels of asparagine, citrulline, glutamine, histidine, methionine, serine, and threonine, compared with COPD patients without bacterial infection (Inoue and Ikeda 2019) . This finding links lung injury with the abnormal metabolism of amino acids under pathological conditions. L-Arginine (Arg), a product of glutamine (via the formation of glutamate) and proline metabolism via the intestinal-renal axis (Wu and Morris 1998) , is a critical substrate for nitric oxide (NO) production by NOS, as noted previously. It has been shown that plasma Arg concentration is reduced in animal models of lung injury, including sheep (Murakami et al. 2007 ), rabbits (Chao et al. 2011; Yoshida et al. 1999) , and rodents (Chu et al. 2005; Mabalirajan et al. 2010) . This is likely due to increases in the expression of arginase-II in extrahepatic tissues and the leakage of hepatic arginase-I and extrahepatic arginase II into the blood, resulting in an excessive hydrolysis of arginine into ornithine plus urea. Supplementation with Arg leads to an increased bioavailability of Arg, which in turn, restores endothelial function, decreases inflammatory response, improves bronchial epithelial barrier, and mitochondrial dysfunction, therefore improving the lung function (Chao et al. 2011; Mabalirajan et al. 2010) . L-Citrulline can be converted into L-argininosuccinate by argininosuccinate synthase, and L-argininosuccinate is subsequently converted into Arg by argininosuccinate lyase (Curis et al. 2005) . These two enzymes are present in the lungs and other tissues in mammals and birds. Oral or intravenous administration of L-citrulline can enhance the circulating levels of Arg and systemic synthesis of NO, thereby attenuating hyperoxia-induced lung damage (Grisafi et al. 2012) . Of particular note, dietary supplementation with arginine, which is safe for healthy adult humans (up to 30 g/day in divided doses; McNeal et al. 2018) as well as growing and adult pigs (up to 2% in the diet; Wu et al. 2016) , prevents or alleviates pulmonary hypertension and injury in humans and farm animals under various pathological conditions (Wu 2020; Wu et al. 2000) . L-Glutamine (Gln) is the most abundant amino acid in the plasma of both humans and many other animals (Wang et al. 2015a) . A critical function of Gln in maintaining intestinal mucosal barrier integrity has been described in various animal models (Jiao et al. 2015; Wu 2013; Wu et al. 2014 ). Depletion of plasma Gln is associated with the impairment of intestinal barrier breakdown, which can be abolished by Gln supplementation in animals and human patients. We have investigated the physiological functions of amino acids in piglets, a well-known animal model for studying nutrition and metabolism. Our studies indicate that dietary supplementation with Gln, glutamate, or glycine attenuates weaning-or oxidative stress-induced epithelial barrier dysfunction by regulating the abundance and intracellular localization of TJ proteins Wang et al. 2015b) , as well as apoptosis Jiao et al. 2015; Liu et al. 2018; Wang et al. 2014 ) and unfolded protein response in piglets. Also, we found that Gln regulates the abundance of TJ proteins and intestinal barrier in a CaMKK2-dependent manner, thereby contributing to improvements in intestinal nutrient absorption and protein synthesis in weanling piglets (Wang et al. 2016; Wang et al. 2015b) . It remains unknown whether these amino acids affect alveolar epithelium in virusor endotoxin-challenged lungs. We have conducted animal studies to address the foregoing issue. In our work, mice pretreated with aerosolized Arg, Gln, or glycine were exposed to aerosolized LPS to induce lung injury. We found that Arg or glycine pretreatment reduced LPS-induced collagen deposition, apoptosis of alveolar cells, decreased mRNA levels for inflammatory cytokines and chemokines, and reduced the accumulation of neutrophils and macrophages in the lung tissues of mice, thus contributing to an improved respiratory function (Ma et al. 2019) . Gln administration reduced LPS-induced collagen deposition and inflammatory cytokines without affecting other parameters examined in the study (Ma et al. 2019 ). More studies are required to uncover underlying mechanisms responsible for these beneficial effects. In a previous study, Zhang et al. (2007) reported that Gln supplementation attenuated an LPSinduced increase in bronchoalveolar epithelial permeability and a concomitant decrease in the abundance of TJ proteins. The latter include occludin, zonula occludens (ZO)-1, and adherens junction protein E-cadherin. Clearly, increasing Gln availability protected the alveolar epithelium against barrier dysfunction and lung injury in rats (Zhang et al. 2007 ). These observations support the view that supplementation with functional amino acids, such as Arg, Gln, or glycine, may offer a novel nutritional strategy to reduce the deleterious effects of bacterial infection on alveolar function. Metabolic programming is one of the important mechanisms by which cellular responses are regulated under specific conditions (Vigeland et al. 2019) . Dysregulation of metabolic reprogramming in lung diseases, such as asthma and COPD, might impair the innate function of immune cells (Michaeloudes et al. 2019) . Gln utilization by lungs and other tissues increases under various stress conditions due to enhanced expression of mitochondrial phosphate-activated glutaminase, such that Gln becomes a conditional essential amino acid (Wilmore and Shabert 1998) . Inhibition of glutamine metabolism with 6-diazo-5-oxo-L-norleucine that binds to glutamineutilizing enzymes and transporters, accelerated recovery from LPS-induced acute lung injury, as shown by reduced immune cell infiltration and decreased protein levels for pro-inflammatory cytokines and chemokines (Vigeland et al. 2019 ). This metabolic programming is mainly due to the fact that immune cells, such as neutrophils, macrophages, and lymphocytes have a high metabolic rate and rely on Gln metabolism to support activation and immune response in response to stress or bacterial infection (Wang et al. 2015a ). Also, a depletion of Gln in blood represents a riskf for poor treatment outcomes and is associated with increased mortality in critical illness (Oudemans-van Straaten et al. 2001 ). Consistently, Gln supplementation reduces abdominal sepsis, or LPS-induced lung injury in animals models (Lai et al. 2014 ). Consistently, a deficiency of ASCT2 (a transporter of Gln and small neutral amino acids) impaired the induc-tion of T helper 1 (Th1) and Th17 cells, attenuated activation of mTORC1 signaling, and inflammatory T cell responses in mouse models, further substantiating a functional role of cellular programming on immunocyte activation and inflammatory responses (Nakaya et al. 2014) . Gln enhances expression of AST2increases its availability in the cells to alleviate the adverse effects of general immune activation (Nakaya et al. 2014 ). In addition, Gln promotes tissue repair by enhancing the production of growth factors by immune cells. For example, EGF-like growth factor, amphiregulin (AREG), is a growth factor produced by macrophages, regulatory T cells, and type-2 innate lymphoid cells in the animal models of lung injury (Xu et al. 2016) . Administration of an antibody to neutralize AREG has been reported to exacerbate LPSinduced lung injury (Ogata-Suetsugu et al. 2017; Xu et al. 2016) . Inhibition of Gln metabolism with 6-diazo-5-oxo-L-norleucine increased the mRNA level of AREG in immune cells, which in turn promoted tissue repair and improved the function of the lungs in mice (Vigeland et al. 2019) . These findings indicate a novel target for the prevention and treatment of lung injury by interfering with the metabolic programming of immunocytes. More studies are warranted to validate these effects in other inflammatory lung diseases and to elucidate the underlying molecular mechanisms. The fibroblast is the most abundant mesenchymal cell responsible for producing the majority of extracellular matrix proteins (Nieweld and Summer 2019) . Differentiation of lung fibroblasts into myofibroblasts leads to excessive deposition of extracellular matrix proteins, which impair the lung architecture and alveoli barrier function (Nalysnyk et al. 2012 ). However, metabolic requirements for myofibroblast activation and matrix production are largely unknown. In a recent study, using human lung fibroblasts as a model, Hamanaka et al. (2019) demonstrated that Gln-derived biosyntheses of glycine and proline through inter-organ metabolism are required for myofibroblast differentiation and collagen protein production in human lung fibroblasts (Hamanaka et al. 2019) . This result has identified a novel metabolic reprogramming of fibroblasts in the development of pulmonary fibrosis. Both glycine and proline are necessary to maintain the extracellular matrix of lungs, and may also play an important role in their anti-oxidative reactions (Li and Wu 2018) . It remains unknown how different host cells regulate their metabolism pathways in response to Gln depletion or supplementation in the body. The innate immune system acts as the first line of defense in response to environmental risk factors. A serial of pathogen recognition receptors (PRRs), such as Toll-like receptors (TLR), RIG-I-like receptors (RLR), protease-activated receptors (PAR), Nod-like receptors (NLR), C-type lectin receptors, sense the pathogens in contact with the airway epithelium (Hartl et al. 2018 ). Nod-like receptors (NLRs), including NOD1, NOD2, and NLRP3, are intracellular pattern recognition molecules that can detect microbial-and danger-associated molecular patterns. NLRP3 inflammasomes is a multiprotein large-cytoplasmic complex that is composed of NLRP3, apoptosis-associated speck-like proteins (ASC), and pro-caspase-1. Activation of NLRP3 has emerged as an important regulator of lung diseases (Xu et al. 2018) . Both LPS and ROS have been reported to activate the NLRP3 inflammasome and caspase-1, promote the cleavage and maturation of pro-interleukin (IL)-1β (biologically the most active cytokine in the lungs of patients), resulting in damage to lung tissue (Xu et al. 2018) . The resistance of NLRP3-deficient mice to polymicrobial sepsis-induced lethality validates a critical role of NLRP3 in the pathogenesis of lung disease Fukumoto et al. 2013; Lee et al. 2017; Liu et al. 2019) . We found that glycine administration reduced the LPS-induced accumulation of neutrophils and macrophages, as well as inflammatory responses and collagen deposition in the lung tissues of mice (Ma et al. 2019) . Further study showed that LPS-induced upregulation of NLPP3 and IL-1β expression was reduced by glycine supplementation (Zhang et al. 2020) , indicating a regulatory effect of glycine on decreasing NLRP3 inflammasomes. Considering that ROS are activators of NLRP3 but glycine alleviates ROS-induced cellular damage by promoting the synthesis of GSH (an endogenous antioxidant) in intestinal porcine epithelial cells , it is plausible that administration of glycine might modulate the NLRP3/IL-1β signaling, therefore improving the lung epithelial barrier in LPS-challenged mice. The nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates the expression of genes implicated in protection against oxidative damage in the lungs and other tissues (Cho and Kleeberger 2020; Mizumura et al. 2020) . Under normal conditions, Nrf2 is continuously degraded in a Kelch-like ECH associated protein (Keap)1-dependent manner through the proteasome pathway. However, in the presence of elevated concentrations of ROS or electrophiles, Nrf2 is stabilized due to the disruption of Keap1mediated repression. This leads to the accumulation of NrF2 in the nucleus to activate the expression of anti-oxidative genes, such as catalytic and modulatory subunits of the GSH synthesizing enzyme glutamate-cysteine ligase (GCLC and GCLM), thioredoxin reductase 1, hemeoxygenase-1 (HO-1), NAD(P)H Quinone Dehydrogenase-1 (NQO-1), xCT, a subunit of cystine/glutamate transporter ). Thus, NrF2 plays an important role in alleviating oxidative damage and improving the function of the lungs. Consequently, Nrf2-knockout mice are more susceptible to LPS-induced lung inflammation than their wild-type counterparts, as indicated by neutrophils infiltration, as well as the elevated levels of proinflammatory cytokines (tumor necrosis factor-α and interleukin-6) and chemokines (macrophage inflammatory protein 2 and magnesium-dependent phosphatase 1) (Li et al. 2017; Thimmulappa et al. 2006 ). In critical illness or in response to severe stress, serum Gln level is decreased which is accompanied by a modest therapeutic outcome and an increased mortality (Oudemans-van Straaten et al. 2001) . Gln supplementation promotes the expression of subunits of the GSH synthesizing enzyme, GCLC and GCLM, in a Nrf2-dependent manner, leading to increases in the synthesis and concentration of GSH and reduced cellular damage in intestinal and lung tissues (Venoji et al. 2015) . In a recent study, de Oliveira et al. (2019) found that Gln treatment reduced myeloperoxidase activity, decreased inflammatory responses, and improved both the morphological alteration and function in the lungs of LPS-challenged mice. We also observed that functional amino acids (e.g., glycine) activated Nrf2 survival signaling, while inhibiting NRLP3 inflammasome (Zhang et al. 2020) , indicating a regulatory effect of amino acids on the Nrf2 signaling pathway. Note that glycine is highly abundant in meat (e.g., beef; Wu et al. 2016 ) but is relatively deficient in all plant-source proteins (Hou et al. 2019; Li and Wu 2020) . Therefore, antioxidant agents or functional foods that modulate Nrf2 would be expected to potentially therapeutic options to alleviate lung injury by enhancing intracellular concentrations of antioxidant molecules (including enzymes) in the alveolar epithelium. Healthy lungs were traditionally believed to be sterile due to their effective antimicrobial defenses (Budden et al. 2017) . This view was challenged by the isolation of bacteria from the respiratory tract of healthy individuals with the use of culture-independent approaches for microbial community profiling (Faner et al. 2017) . Compared with the gastrointestinal tract where more than 100 trillion microorganisms reside, the lungs of humans and animals harbor 10 3 -10 5 CFU/g of tissue (Remot et al. 2017) , with Bacteroides, Firmicutes and Proteobacteria being the predominant phyla commonly observed (He et al. 2017 ). There is a relatively much lower abundance of bacteria in the lungs than in the gastrointestinal tract. However, increasing evidence indicates that lung microbiota dysbiosis is a critical environmental factor that interacts with host cells and contributes to the pathogenesis of multiple lung diseases through various mechanisms (Dickson et al. 2013; He et al. 2017; Wu and Segal 2017) . First, microbes play an important role in shaping the normal and pathologic immune responses in lungs (He et al. 2017 ). Deregulation of microbiota in the lungs may predispose humans and other animals to the development of respiratory disease, and has a significant impact on clinical outcomes of respiratory disorders (Segal et al. 2014) . Also, the microflora in the lungs can translocate to the gastrointestinal tract and other tissues through blood circulation, therefore triggering inflammatory responses (Sze et al. 2014) . Additionally, intestinal bacteria influence the composition and diversity of microbiota in the lungs, therefore forming a bidirectional gut-lung axis (Budden et al. 2017; He et al. 2017 ). More studies are required to uncover the complicated crosstalk between the lungs and gut, as well as their impacts on health. It is known that the intestinal microbiota affects the physiology, metabolism, and immunity of the host through: (a) interactions with enterocytes and immune cells of the gastrointestinal tract; and (b) the production of bacterial metabolites. Studies with pigs have shown that most of the amino acids in the intestinal lumen can be utilized by intestinal bacteria for protein synthesis and catabolism at various rates (Dai et al. 2012a; Dai et al. 2011) , therefore affecting the proportions of dietary amino acids entering the portal vein, as well as the availability of amino acids for various cells in the lungs and colonized bacteria. This may be a reason why the intestinal microbiota affects the development of lung diseases as observed in clinical patients and experimental animals (O'Dwyer et al. 2016) . Of note, dietary supplementation with functional amino acids (e.g., Gln, Trp and Arg) has been reported to regulate the bacterial ecosystem of the gut and improve the intestinal health of animals (Dai et al. 2012b (Dai et al. , 2013 Liang et al. 2019; Wang et al. 2020 ). To extend this observation, we conducted an experiment involving mice pretreated with aerosolized arginine, glutamine, or glycine before exposure to aerosolized LPS (13). Each of these three amino acids was found to have beneficial effects on reducing LPS-induced lung injury (Ma et al. 2019) . Although arginine supplementation can stimulate the production of NO (a potential oxidant) by LPS-activated macrophages, other benefits of this amino acid may contribute to its role in alleviating the infiltration of neutrophils into the lung tissues and in improving alveolar integrity and function. More studies are needed to explore whether the beneficial effect of the functional amino acids is associated with microbiota alterations in the lungs of animals. Studies from clinical patients and animal models have provided enormous amounts of data on the development to lung injury (including inflammatory cell infiltration and morphological alterations), as well as the cellular and molecular events underlying the pathogenesis. Recent studies have shown that certain amino acids are critically important nutrients for maintaining the integrity and the functionality of the lungs by promoting the syntheses of proteins, bioactive compounds, and nucleic acids, which are required for cell proliferation, immune response, and cellular homeostasis. Accumulating evidence indicates that depletion of amino acids or deregulation of amino acid metabolism is associated with the development of multiple lung diseases. Amino acid supplementation improves lung homeostasis by regulating mucosal barrier function, inhibiting apoptotic cell death, and restoring the integrity of epithelial barrier via multiple signaling pathways. However, there is a long way to translate the basic research into clinical applications for the treatment of patients with lung disease. First, lung injury is a complicated pathological process and multiple types of cells (including endothelial cells, epithelium, smooth muscle cells, and fibroblasts) contribute to the dysfunction of the lungs. It remains unknown how these cells respond to amino acids under various physiological and pathological conditions. Second, amino acids have been reported to alleviate inflammatory responses and improve lung function. However, underlying mechanisms are not well defined and more studies are required to fulfill this gap of knowledge before their applications to clinical medicine. Third, most of our understanding and observations are based on studies with rodents. Despite a high degree of similarity in nutrition, physiology and immunology between mice and humans, it should be borne in mind that no animal models can fully mimic human disease. Thus, precautions should be taken not to simply extrapolate results from animals to humans. Also, data from various animal studies are not always consistent and sometimes are very different, due to differences in experimental designs, animal models, the duration and dosage of chemical exposure, methods for analysis, and the interpretation of results. Careful studies and a critical thinking are required to draw a convincing conclusion. Furthermore, because viruses [e.g., coronavirus (COVID-19, Shi et al. 2020) and influenza virus (Herold et al. 2015) ] induce severe damage to the lungs, it is important to determine whether dietary supplementation or intravenous administration of individual functional amino acids (e.g., arginine-HCl, citrulline, N-acetylcysteine, glutamine, glycine, proline and tryptophan) or their combinations to affected subjects may ameliorate injury and dysfunction in this vital organ. Finally, because air pollution impairs the development of organs (particularly lungs; Wu et al. 2019) , effects of environmental pollutants (e.g., PM 2.5 particles) on amino acid metabolism in the lungs and nutritional methods involving the use of amino acid supplementation to alleviate respiratory disorders should be investigated. Biochemical and pathophysiological properties of polyamines Update on the pathogenesis of chronic obstructive pulmonary disease Serine and glycine metabolism in cancer New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways Glutathione biosynthesis in the isolated perfused rat lung: utilization of extracellular glutathione The effect of captopril on lipopolysaccharide-induced lung inflammation Recent developments in the management of acute respiratory distress syndrome in adults Emerging pathogenic links between microbiota and the gut-lung axis Pulmonary perfusion with L-arginine ameliorates post-cardiopulmonary bypass lung injury in a rabbit model Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway Mitochondrial biology in airway pathogenesis and the role of NRF2 L-arginine prevents air embolism-induced acute lung injury in rats Almost all about citrulline in mammals Amino acid metabolism in intestinal bacteria: links between gut ecology and host health Metabolism of select amino acids in bacteria from the pig small intestine Regulatory role for L-arginine in the utilization of amino acids by pig small-intestinal bacteria L-glutamine regulates amino acid utilization by intestinal bacteria Glutamine therapy reduces inflammation and extracellular trap release in experimental acute respiratory distress syndrome of pulmonary origin The role of the bacterial microbiome in lung disease Glycine supplementation to breast-fed piglets attenuates post-weaning jejunal epithelial apoptosis: a functional role of CHOP signaling The microbiome in respiratory medicine: current challenges and future perspectives NLRP3 deletion protects from hyperoxia-induced acute lung injury Reactive nitrogen and oxygen species in airway inflammation Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation Management of phosgeneinduced acute lung injury L-citrulline prevents alveolar and vascular derangement in a rat model of moderate hyperoxiainduced lung injury Role of oxidants in lung injury during sepsis Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts Innate immunity of the lung: from basic mechanisms to translational medicine Gutlung axis: the microbial contributions and clinical implications Influenza virus-induced lung injury: pathogenesis and implications for treatment L-glutamine represses the unfolded protein response in the small intestine of weanling piglets Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions Nutritionally nonessential amino acids: a misnomer in nutritional sciences Dietary essentiality of "nutritionally non-essential amino acids" for animals and humans Composition of polyamines and amino acids in plant-source foods for human consumption Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD L-glutamate enhances barrier and antioxidative functions in intestinal porcine epithelial cells Primary structure and functional characterization of a high-affinity glutamate transporter Amino acid transporters revisited: new views in health and disease Human alveolar epithelial cell injury induced by cigarette smoke The effect of L-arginine on ciliary beat frequency in PCD patients, non-PCD respiratory patients and healthy controls Glutamine attenuates acute lung injury caused by acid aspiration Allergens and the airway epithelium response: gateway to allergic sensitization Oxidant-antioxidant balance in acute lung injury NLRP3 inflammasome deficiency protects against microbial sepsis via increased lipoxin B4 synthesis Nrf2 regulates the risk of a diesel exhaust inhalationinduced immune response during bleomycin lung injury and fibrosis in mice Roles of dietary glycine, proline and hydroxyproline in collagen synthesis and animal growth Composition of amino acids and related nitrogenous nutrients in feedstuffs for animal diets Dietary l-tryptophan supplementation enhances the intestinal mucosal barrier function in weaned piglets: Implication of tryptophanmetabolizing microbiota L-Glutamine attenuates apoptosis in porcine enterocytes by regulating glutathione-related redox homeostasis Ventilator-induced lung injury is alleviated by inhibiting NLRP3 inflammasome activation Glutamine synthetase gene expression in the lungs of endotoxin-treated and adrenalectomized rats Protective effects of functional amino acids on apoptosis, inflammatory response, and pulmonary fibrosis in lipopolysaccharide-challenged mice L-Arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation Caveolin-1-derived peptide limits development of pulmonary fibrosis Allergy as an epithelial barrier disease The quantitative determination of phenylalanine hydroxylase in rat tissues. Its developmental formation in liver Safety of dietary supplementation with arginine in adult humans Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases Role of Nrf2 in the pathogenesis of respiratory diseases L-arginine attenuates acute lung injury after smoke inhalation and burn injury in sheep Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Activated fibroblasts: gluttonous for glutamine The lung microbiome, immunity and the pathogenesis of chronic lung disease Amphiregulin suppresses epithelial cell apoptosis in lipopolysaccharide-induced lung injury in mice Plasma glutamine depletion and patient outcome in acute ICU admissions Redox regulation of motile cilia in airway disease PICK1 deficiency exacerbates sepsisassociated acute lung injury and impairs glutathione synthesis via reduction of xCT Glutathione, stress responses, and redox signaling in lung inflammation Bacteria isolated from lung modulate asthma susceptibility in mice Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Lung glutamine metabolism Epithelial dysfunction in chronic respiratory diseases, a shared endotype? Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37 Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide Enteral glutamine differentially regulates Nrf 2 along the villuscrypt axis of the intestine to enhance glutathione levels Inhibition of glutamine metabolism accelerates resolution of acute lung injury Glycine stimulates protein synthesis and inhibits oxidative stress in pig small intestinal epithelial cells Glutamine and intestinal barrier function Glutamine enhances tight junction protein expression and modulates corticotropin-releasing factor signaling in the jejunum of weanling piglets L-glutamine enhances tight junction integrity by activating CaMK kinase 2-AMP-activated protein kinase signaling in intestinal porcine epithelial cells Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells Dietary L-tryptophan supplementation regulates colonic serotonin homeostasis and inhibits gut inflammation in mice with dextran sodium sulfate-induced colitis A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity NOX modifiers-just a step away from application in the therapy of airway inflammation? Role of glutamine in immunologic responses Dietary requirements of synthesizable amino acids by animals: a paradigm shift in protein nutrition Management of metabolic disorders (including metabolic diseases) in ruminant and nonruminant animals Arginine metabolism: nitric oxide and beyond Lung microbiota and its impact on the mucosal immune phenotype Endogenous synthesis of arginine plays an important role in maintaining arginine homeostasis in postweaning growing pigs Arginine nutrition in development, health and disease Amino acid nutrition in animals: protein synthesis and beyond Composition of free and peptidebound amino acids in beef chuck, loin, and round cuts Adverse organogenesis and predisposed long-term metabolic syndrome from prenatal exposure to fine particulate matter Classically activated macrophages protect against lipopolysaccharide-induced acute lung injury by expressing amphiregulin in mice Inflammasome in the pathogenesis of pulmonary diseases L-arginine inhibits ischemia-reperfusion lung injury in rabbits Effects of chronic ethanol ingestion on tight junction proteins and barrier function of alveolar epithelium in the rat Reactive oxygen species stimulated pulmonary epithelial cells mediate the alveolar recruitment of FasL(+) killer B cells in LPS-induced acute lung injuries Glycine attenuates lipopolysaccharide-induced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling Acknowledgments This work was supported by the National Natural Science Foundation of China (No. 31572423, and 31625025), the "111" Project (B16044), Jinxinnong Animal Science Development Foundation, and Texas A&M AgriLife Research (H-8200). Y.Y. and G.W. designed the review; J.C., Y. J., Y.Y., Z.W., and G.W. drafted the manuscript; Z.W., Y. Y., and G.W. revised and finalized the manuscript. Y.Y. and G.W. had primary responsibility for final content. All authors read and approved the final manuscript.